Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jonathan Thon
Brigham and Women's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Platelet BioGenesis
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Please see attached document for further details.
Examination of the Final Stages of Platelet Production
PROJECT NARRATIVE - Examination of the Final Stages of Platelet Production Relevance to public health. Platelets are essential to control bleeding and platelet transfusions are widely used to treat patients with inherited or acquired thrombocytopenia (low platelet counts) resulting from immune thrombocytopenic purpura, myelodysplastic syndromes, aplastic anemia, complications during pregnancy and birth, human immunodeficiency virus infection, chemotherapy and surgery. Although more than 10 million platelet units are transfused yearly in the United States, the limited availability of donor platelets owing to their 5-day shelf life, potential to induce an immune response and risk of bacterial contamination is of serious clinical concern. A better understanding of the mechanisms of platelet formation will lead to improved therapies for thrombocytopenia and an alternative source of platelets for infusion.
Filed on May 05, 2014.
Tell us what you know about Jonathan Thon's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Jonathan Thon”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jonathan Thon | University of Washington | Conflict of Interest | Platelet BioGenesis | Value cannot be readily determined |
| Jonathan Thon | Brigham and Women's Hospital | Conflict of Interest | Platelet BioGenesis | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.